Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Observational × AIDS-Related Opportunistic Infections × Clear all
NCT00000860 2005-06-24

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

National Institute of Allergy and Infectious Diseases (NIAID)

Completed
24 enrolled

Mycobacterium avium-intracellulare Infection, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡